Structure Therapeutics Inc.
Develops oral small molecule drugs for chronic conditions like metabolic diseases and obesity.
GPCR | US
Overview
Corporate Details
- ISIN(s):
- US86366E1064
- LEI:
- Country:
- United States of America
- Address:
- 601 GATEWAY BLVD SUITE 900, 94080 SOUTH SAN FRANCISCO
- Website:
- https://structuretx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Structure Therapeutics is a clinical-stage global biopharmaceutical company that discovers and develops novel oral small molecule therapeutics. The company leverages advanced computational and structure-based drug design technologies to create treatments for a wide range of chronic conditions, with a focus on metabolic diseases such as obesity.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Structure Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Structure Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Structure Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
